Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Current Leases (2019 - 2025)

Historic Current Leases for STRATA Skin Sciences (SSKN) over the last 7 years, with Q3 2025 value amounting to $266000.0.

  • STRATA Skin Sciences' Current Leases fell 1739.13% to $266000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $266000.0, marking a year-over-year decrease of 1739.13%. This contributed to the annual value of $328000.0 for FY2024, which is 681.82% down from last year.
  • As of Q3 2025, STRATA Skin Sciences' Current Leases stood at $266000.0, which was down 1739.13% from $303000.0 recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Current Leases ranged from a high of $404000.0 in Q3 2023 and a low of $224000.0 during Q2 2022
  • Moreover, its 5-year median value for Current Leases was $328000.0 (2024), whereas its average is $328473.7.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 4151.44% in 2022, then soared by 7500.0% in 2023.
  • Over the past 5 years, STRATA Skin Sciences' Current Leases (Quarter) stood at $318000.0 in 2021, then grew by 11.64% to $355000.0 in 2022, then fell by 0.85% to $352000.0 in 2023, then decreased by 6.82% to $328000.0 in 2024, then fell by 18.9% to $266000.0 in 2025.
  • Its Current Leases stands at $266000.0 for Q3 2025, versus $303000.0 for Q2 2025 and $331000.0 for Q1 2025.